OCCI offers a 23.3% yield, but declining NAV, poor earnings, and high-risk CLO exposure suggest caution. Read more on why I ...

A federal appeals court on Friday struck down 2023 regulations adopted by the U.S. Securities and Exchange Commission on ...

It’s an exciting time in the stock market right now with the major U.S. indexes eclipsing their former all-time highs. As we ...

Coursera's strong Q2 beat, accelerating growth, and improved free cash flow reinforce my bullish stance. Click here to find ...

Valuations are low, tax laws have shifted, and technical trends are turning—Wall Street is starting to reconsider the ...

Ramon Ang's San Miguel Global Power buys P3.9 billion worth of shares held by Land Bank in Meralco after courts clear the transaction ...

The Christopher & Dana Reeve Foundation, started by the late Superman actor and his wife, raises more than $1 million a year ...

After months of turbulence, mid- and small-cap indices are showing signs of life this July. With mutual fund inflows ...

Trading Standards is calling for urgent regulation of the new class of addictive products sold to children following the ban ...

Multiplex chains like PVR Inox, Cinepolis, and Miraj are expanding into tier 2 and 3 cities and South India, eyeing regions ...

Pete O'Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company's pioneering work in fibroblast-based cell therapies.

Throughout most of recent history, small-cap stocks have dramatically underperformed their large-cap counterparts. Over the past 10 years, the Vanguard Russell 2000 ETF ( VTWO) that tracks the popular ...